Sexual health

Why STI Tests Give False Positives and Negatives

Save

No test is perfect, and knowing how STI tests fail makes a confusing result far less frightening. Timing explains most false negatives; sampling technique and cross-reactivity explain the rest. A handful of tests, like the herpes antibody blood test, produce enough false positives that expert panels advise against using them for routine screening. Here is why each kind of error happens, and what a result that does not add up should prompt you to do next.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Can an STI test actually be wrong?

Yes, in two different directions. A false negative says you are clear when you are not; a false positive says you are infected when you are not. Both are uncommon with today's tests, and both cluster in a few predictable situations rather than happening at random. Understanding which situation you are in usually explains the result.

A test result is not the end of the story — it is information that changes a decision, and its value depends on the benefits and harms of acting on it, not on accuracy in the abstract 1. That framing matters here: the same imperfect test can be reassuring in one context and misleading in another, depending on how likely infection was before you tested. The rest of this page walks through why each error happens and what it should prompt.

False negatives: testing inside the window period

The most common reason a real infection reads negative is timing. Every STI test has a window period — the gap between exposure and when the test can reliably detect the infection or your body's response to it. Test before that window closes and the result can be a true-looking negative on a real infection. This is a mismatch of timing, not a broken test 2.

HIV is the clearest example: a nucleic acid test can detect infection roughly 10 to 33 days after exposure, a laboratory antigen/antibody test around 18 to 45 days, and a rapid antibody test as late as 23 to 90 days 2. Other infections have their own windows. A negative result only rules out what your body had time to show by the day you tested. If you tested within days of a possible exposure, the practical move is to test again once enough time has passed — the same instinct behind looking up when to test after exposure for each infection.

False negatives: the sample came from the wrong place

A test can only find an infection where you collected the sample. Gonorrhea and chlamydia can live in the throat and rectum as well as the genitals, so a urine sample alone can miss an infection picked up through oral or anal sex. If the exposed site is not swabbed, the result can be falsely reassuring even with a flawless laboratory test.

Self-collection generally works well, and CDC notes that self-collected samples are an accepted option for several infections 3. The accuracy problem is not usually the swab; it is which sites get sampled. Asking specifically for testing of every exposed site — genital, throat, and rectal as relevant — closes this gap. Testing the wrong target matters too: some newer infections are only worth checking under specific circumstances, which is why not every panel screens for every organism.

False positives: why the herpes blood test is the classic example

False positives are less about a broken machine and more about testing the wrong person with the wrong test. The blood (serologic) test for genital herpes is the textbook case. In 2023 the US Preventive Services Task Force reaffirmed its recommendation against routine serologic HSV screening in people without symptoms, giving it a Grade D, specifically because the test's poor specificity produces too many false positives and net harm 4.

CDC guidance lines up with this: routine type-specific herpes antibody screening is not recommended for asymptomatic people, and testing is instead directed at lesions when symptoms are present 5. A positive herpes antibody result in someone with no symptoms is exactly the situation the guidelines warn can be a false positive. The lesson generalizes: a test run on a low-risk person, for an infection they were unlikely to have, turns more of its positives into false alarms.

Sensitivity and specificity, in plain language

Two numbers describe how a test errs. Sensitivity is how well it catches real infections; specificity is how well it clears people who are truly uninfected. The FDA-approved oral HIV self-test, for example, has an expected sensitivity of about 92% and specificity of about 99.98% 6. A sensitivity of 92% means a handful of true infections can read negative; a specificity near 99.98% means false positives are very rare.

There is a second, less intuitive factor: how likely infection was before you tested. When infection is unlikely to begin with, even a very accurate test throws off more false positives relative to true ones, because there are so few real cases to find. That is why a test's real-world usefulness depends on the decision it informs and the person taking it, not on the accuracy figure alone 1. It is also why guidelines match specific tests to specific risk groups.

What to do when a result does not fit

When a result clashes with your symptoms or your history, the answer is rarely to trust it blindly. A negative test taken inside the window is worth repeating once the window has closed 2. A positive screening test — for HIV and for several other infections — is normally followed by a confirmatory test before it becomes a diagnosis, precisely to catch the rare false positive. Keeping a simple note of the exposure date, the day you tested, and which sites were sampled gives a clinician what they need to judge whether a repeat is warranted.

Some results come back neither positive nor negative but equivocal, and understanding what an indeterminate sti result means usually calls for a repeat or a different testing method rather than panic. An equivocal or indeterminate result is a signal to retest, not a verdict. In every case, the useful next step is a conversation with a clinician who can weigh the result against your exposure history, your symptoms, and whether the right test was run on the right sample at the right time.

Common questions

Yes, most often if you tested inside the window period, before the infection became detectable, or if the sample was not collected from the site that was actually exposed. A negative result taken soon after a possible exposure is best repeated once enough time has passed. Persistent symptoms after a negative test are also a reason to test again or test differently.

The herpes antibody blood test has relatively poor specificity, which means it produces a meaningful number of false positives, especially in people without symptoms. That is why expert panels recommend against routine herpes blood screening for asymptomatic people. A positive result in that situation is worth discussing with a clinician and, when possible, confirming rather than accepting at face value.

It can. Cross-reactivity, where a test reacts to antibodies or substances unrelated to the target infection, is one mechanism, and it is part of why certain antibody tests are less specific. Testing a person at low risk for an infection they were unlikely to have also raises the share of positives that turn out to be false. Confirmatory testing is designed to sort this out.

Retesting makes sense when timing or sampling could have thrown off the result: a negative taken inside the window, a positive screening test awaiting confirmation, an equivocal result, or symptoms that do not match the result. Retesting for its own sake, well outside any window and with no symptoms, usually adds little. A clinician can tell you which situation applies.

Well-designed at-home and mail-in tests use the same laboratory methods as clinic testing, so their accuracy is comparable when the sample is collected correctly and taken from the right site. The same window-period and sampling rules apply. A positive at-home result should be confirmed, and a negative taken soon after a possible exposure should be repeated later.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a test result should not be the last word

  • —Persistent genital, anal, or throat symptoms — discharge, sores, burning, or pain — despite a negative STI test
  • —A negative test taken within days of a known high-risk exposure, before the window period had closed
  • —A positive screening result that has not yet been confirmed with a follow-up or confirmatory test

This article explains why STI tests can give false results and is general information, not a diagnosis. A result that does not match your symptoms or exposure history is best interpreted by a clinician who can order the right confirmatory or repeat testing.

References

  1. 1.Schünemann HJ, Oxman AD, Brozek J, et al. (2008). Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. doi:10.1136/bmj.39500.677199.AEThat a test's value depends on the downstream benefits and harms of the true and false positives and negatives it produces, not on accuracy alone, because a test only helps through the decisions it changes.
  2. 2.Centers for Disease Control and Prevention (2024). Clinical Testing Guidance for HIV. CDC HIV Nexus. linkThe HIV window periods by test type (NAT about 10-33 days, lab antigen/antibody about 18-45 days, rapid antibody about 23-90 days), used to illustrate why a test taken too early can miss a real infection.
  3. 3.Centers for Disease Control and Prevention (2024). Getting Tested for STIs. CDC (cdc.gov/sti). linkThat self-collection options exist for STI testing and that testing recommendations are specific to who should be tested for which infections.
  4. 4.US Preventive Services Task Force (2023). Genital Herpes Infection: Serologic Screening. US Preventive Services Task Force (reaffirmation, JAMA 2023). link ✓The 2023 USPSTF Grade D recommendation against routine serologic screening for genital herpes in asymptomatic people, because of the test's poor specificity (high false-positive rate) and net harm.
  5. 5.Centers for Disease Control and Prevention (2024). Screening for Genital Herpes. CDC (cdc.gov/herpes). linkThat routine type-specific serologic HSV screening is not recommended for asymptomatic people, and that herpes testing is instead directed at lesions when symptoms are present.
  6. 6.U.S. Food and Drug Administration (2022). Information regarding the OraQuick In-Home HIV Test. FDA.gov. link ✓That the FDA-approved oral-fluid HIV self-test has an expected sensitivity of about 92% and specificity of about 99.98%, used to illustrate sensitivity and specificity in plain language.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library